[1] 杨娉婷, 徐泳, 王家宁,等. 系统性红斑狼疮并发神经精神性狼疮[J]. 中国实用内科杂志, 2015, 35(10): 828
[2] Magro-Checa C, Schaarenburg R A, Beaart H J, et al. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus[J]. Lupus, 2016, 25(8): 878
[3] 王会会, 陈国江, 黎燕,等. 补体C5a、C5a受体及其拮抗剂的研究进展[J]. 国际药学研究杂志, 2010, 37(3): 181
[4] Monk P N, Scola A M, Madala P, et al. Function, structure and therapeutic potential of complement C5a receptors[J]. Brit J Pharmacol, 2010, 152(4): 429
[5] Sakuma Y, Nagai T, Yoshio T, et al. Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus[J]. Japan J Rheumatol, 2016, 27(2): 292
[6] Mahajan S D, Parikh N U, Woodruff T M, et al. C5a alters blood–brain barrier integrity in a human in vitro model of systemic lupus erythematosus[J]. Immunology, 2015, 146(1):130
[7] Hochberg M C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthr itis Rheum, 1997, 40(9): 1725
[8] The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum, 1999, 42(4): 599
[9] Lang M H, Sarma J V, Zetoune F S, et al. Generation of C5a in the absence of C3: a new complement activation pathway[J]. Mol Immunol, 2006, 44(1): 235
[10] Short A, Wong A K, Finch A M, et al. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat[J]. Br J Pharmacol, 2010, 126(3): 551
[11] Jacob A, Hack B, Chen P, et al. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB[J]. J Neurochem, 2011, 119(5): 1041
[12] Jacob A, Hack B, Bai T, et al. Inhibition of C5a receptor alleviates experimental CNS lupus[J]. J Neuroimmunol, 2010, 221(1): 46
[1]陈 宪,周 蕾,庞 杰,等.血尿酸与系统性红斑狼疮患者肾损害的关系[J].天津医科大学学报,2014,20(01):42.
CHEN Xian,ZHOU Lei,PANG Jie,et al.Association of serum uric acid with lupus nephritis in systemic lupus erythematosus patients[J].Journal of Tianjin Medical University,2014,20(04):42.
[2]李晓洁,周 蕾,陈 宪,等.超敏C反应蛋白和补体C3与系统性红斑狼疮疾病活动度的关系[J].天津医科大学学报,2015,21(03):63.
LI Xiao-jie,ZHOU Lei,CHEN Xian,et al.Relationship between high-sensitivity C-reactive and complement 3 and disease activity in systemic lupus erythematosus[J].Journal of Tianjin Medical University,2015,21(04):63.
[3]李晓洁,周 蕾,陈 宪,等.超敏C反应蛋白和补体C3与系统性红斑狼疮疾病活动度的关系[J].天津医科大学学报,2015,21(01):63.
LI Xiao-jie,ZHOU Lei,CHEN Xian,et al.Relationship between high-sensitivity C-reactive protein, complement 3 andwith disease activity in systemic lupus erythematosus[J].Journal of Tianjin Medical University,2015,21(04):63.
[4]徐 萍,周 蕾.血清β2-微球蛋白与系统性红斑狼疮疾病活动度及其肾脏损害的相关性[J].天津医科大学学报,2017,23(01):41.
XU Ping,ZHOU Lei.Relationship between serum levels of β2-microspheres and disease activity together with renal damage in systemic lupus erythematosus patients[J].Journal of Tianjin Medical University,2017,23(04):41.
[5]赵 冕,朱桂晋,周 蕾.系统性红斑狼疮患者血清IL-17和IL-35水平及其与肾损害的关系[J].天津医科大学学报,2019,25(04):359.
ZHAO Mian,ZHU Gui-jin,ZHOU Lei.Serum IL-17 and IL-35 levels in patients with systemic lupus erythematosus and their correlations with renal damage[J].Journal of Tianjin Medical University,2019,25(04):359.